ArticleScientific reports2026
Bio-efficacy of Syzygium aromaticum bud extract as eco-friendly green acaricide for controlling Hyalomma dromedarii.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The most common hard tick in Egypt is Hyalomma dromedarii as a one of the most dangerous ectoparasites. The current study aims to detect the chemical composition of Syzygium aromaticum bud ethanolic extract using GC-MS and some phytochemical analysis in addition to investigating its acaricidal activity on H. dromedarii engorged females through biological and biochemical studies. The GC-MS revealed the presence of eugenol, eugenol acetate and D-(-)-fructofuranose as the most active compounds, and it appeared to be rich in alkaloids, flavonoids, phenolic compounds, tannins and terpenoids. At high concentration, the extract caused mortality to reach 100% after 35 days of treatment in engorged females, with LC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.